INS and Other metabolic disease: In this setting, the identification of SPISE, a lipids and BMI derived index of insulin sensitivity, as a novel predictor of impaired glucose-insulin metabolism, provides a unique tool to be used in clinical practice for phenotyping children at high risk of metabolic diseases, such as those with obesity.